Liquid biopsies in renal cell carcinoma with focus on epigenome analysis
| dc.contributor.author | Cimadamore, Alessia | |
| dc.contributor.author | Santoni, Matteo | |
| dc.contributor.author | Massari, Francesco | |
| dc.contributor.author | Cheng, Liang | |
| dc.contributor.author | Lopez-Beltran, Antonio | |
| dc.contributor.author | Scarpelli, Marina | |
| dc.contributor.author | Montironi, Rodolfo | |
| dc.contributor.department | Pathology and Laboratory Medicine, School of Medicine | en_US |
| dc.date.accessioned | 2020-02-24T14:45:29Z | |
| dc.date.available | 2020-02-24T14:45:29Z | |
| dc.date.issued | 2019-09 | |
| dc.eprint.version | Final published version | en_US |
| dc.identifier.citation | Cimadamore, A., Santoni, M., Massari, F., Cheng, L., Lopez-Beltran, A., Scarpelli, M., & Montironi, R. (2019). Liquid biopsies in renal cell carcinoma with focus on epigenome analysis. Annals of translational medicine, 7(Suppl 6), S194. https://doi.org/10.21037/atm.2019.07.30 | en_US |
| dc.identifier.uri | https://hdl.handle.net/1805/22115 | |
| dc.language.iso | en_US | en_US |
| dc.publisher | AME Publishing Company | en_US |
| dc.relation.isversionof | 10.21037/atm.2019.07.30 | en_US |
| dc.relation.journal | Annals of Translational Medicine | en_US |
| dc.rights | Publisher Policy | en_US |
| dc.source | PMC | en_US |
| dc.subject | Liquid Biopsies | en_US |
| dc.subject | Renal Cell Carcinoma | en_US |
| dc.subject | Epigenome Analysis | en_US |
| dc.subject | mRNA expression | en_US |
| dc.subject | SHOX2 ccfDNA Methylation Testing | en_US |
| dc.subject | Nephrectomy | en_US |
| dc.subject | ccfDNA | en_US |
| dc.subject | Non-invasive Biomarkers | en_US |
| dc.subject | Personalized Treatment Changes | en_US |
| dc.title | Liquid biopsies in renal cell carcinoma with focus on epigenome analysis | en_US |
| dc.type | Article | en_US |
| ul.alternative.fulltext | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789363/ | en_US |